Formulation advantages: The palmitoyl group on Matrixyl confers lipophilicity, which enhances penetration through the hydrophobic stratum corneum
Furthermore, the PPAR- agonist, WY14643, seems to reduce the renal dysfunction and injury associated with I/R (Sivarajah et al., 2002), while benzafibrate inhibits cisplatin-mediated injury by preventing the proximal tubule cell death (Nagothu et al., 2005)
Potential risk factors that have been studied include exposure to certain chemicals or drugs before birth, viral infections (such as rubella and influenza) that occur during pregnancy, and other maternal illnesses including diabetes and phenylketonuria
According to the observed safe level (OSL) risk assessment method, evidence of safety is strong with doses up to 1,200 mg/day of coenzyme Q 10 (108)